bioAffinity Technologies, Inc. (BIAF) vs BioRestorative Therapies, Inc. (BRTX)

A side-by-side comparison of bioAffinity Technologies, Inc. and BioRestorative Therapies, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BIAF vs BRTX

growth of $100 · dividends reinvested · last 4y
BIAF -99.8% (-79.8%/yr)BRTX -96.4% (-56.5%/yr)BRTX compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $1002023202420252026$0$4
BIAF BRTX

BIAF vs BRTX: by the numbers

  • •BRTX is the larger company ($3M vs $3M market cap).
  • •Both run net losses; BIAF's is the smaller (-257.33% vs -3089.55% net margin).

Metrics side by side

Valuation

MetricBIAFBRTX
P/S ratio0.478.49
P/B ratio0.731.00

Profitability

MetricBIAFBRTX
Gross margin23.21%92.09%
Operating margin-171.58%-4350.05%
Net margin-257.33%-3089.55%
ROE-402.92%-365.43%
ROIC-237.93%-464.86%

Growth (annualized)

MetricBIAFBRTX
Revenue CAGR (5Y)N/A38.99%
Total return CAGR (5Y)N/A-61.44%

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.